Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New report offers a blueprint for prudent investments in technology, through which governments can create effective and fair health and education services.

© Shutterstock

Well-considered investments in digital technology can be transformational for health and education services across the developing world, but too often they fail to deliver impact at scale, according to research released today by the Oxford University-based Pathways for Prosperity Commission on Technology and Inclusive Development.

Melinda Gates, co-chair of the Pathways Commission, said: “Better health and education for young people – the twin engines of what economists call ‘human capital’ – could drive the next phase of economic progress in developing countries, but only if governments design policies to ensure technology reaches the most marginalized communities.”

The Commission’s new report, Positive disruption: health and education in a digital agehas found that silver bullet initiatives, focussing only on technological hardware, such as introducing laptops in classrooms, are often not effective beyond the initial pilot. This is usually due to policy makers adopting a piecemeal approach, which fails to consider the wider system in which the technology is being used.

However, the research finds that by looking at entire health and education systems, and deploying technology at strategic points, countries can provide health and education that works for all.

Read more (University of Oxford website)

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.